The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patients’ quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Group’s ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).
SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. The Cancer Screening in 5 Continents (CanScreen5) project of the Group aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes. For example, the Group significantly contributed also to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.
Srabani Mittal (15 August 1965–10 August 2019)14/08/2019
The Screening Group (SCR) team is saddened by the passing of long-time SCR collaborator Doctor Srabani Mittal from Kolkata, India, who died on Saturday 10 August 2019 in Dhaka, Bangladesh.
Read the IARC news.
Registration of new trainers and trainees for the IFCPC-IARC Training course in Colposcopy and the prevention of Cervical Cancer14/08/2019
Registration of new trainers and trainees for the IFCPC-IARC Training course in Colposcopy and the prevention of Cervical Cancer will be open at the IFCPC-IARC stall at the 33rd Annual Conference of AICC RCOG 2019.
Exciting new opportunities for the trainers and trainees.
For further details about this training and registration.
Workshop on Early detection of cervical and breast cancer in Kolkata, India – 08/09/201914/08/2019
As part of the 33rd Annual Conference of AICC RCOG 2019, a post-congress workshop will be organized by IARC and IFCPC. Faculty include Dr. R. Sankaranarayanan, Dr Partha Basu, Dr. Neerja Bhatla and Dr. Theresa Freeman Wong.
More details available here for the registration.
|Vale D.B., Anttila A., Ponti A., Senore C., Sankaranarayanan R., Ronco G., Segnan N., Tomatis M., Žakelj M.P., Elfstrom K.M., Lonnberg S., Dillner J., Basu P. Response to the author: invitation to cancer screening: putting the car before the horse? Eur J Cancer Prev. 2019 Sep;28(5):458-459.|
|Sangrajrang S., Laowahutanont P., Wongsena M., Muwonge R., Imsamran W., Ploysawang P., Basu P. Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women. J Med Screen. 2019 Jul 31.|
|Vale D.B., Filho C.C., Shinzato J.Y., Spreafico F.S., Basu P., Zeferino L.C. Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis. BMC Cancer. 2019 May 10;19(1):432.|